RESUMEN
The genome of the Nipah virus (NiV) encodes a variety of structural proteins linked to a diverse array of symptoms, including fevers, headaches, somnolence, and respiratory impairment. In instances of heightened severity, it can also invade the central nervous system (CNS), resulting in more pronounced problems. This work investigates the effects of NiV on the blood-brain barrier (BBB), the vital physiological layer responsible for safeguarding the CNS by regulating the passage of chemicals into the brain selectively. To achieve this, the researchers (MMJAO, AM and MNMD) searched a variety of databases for relevant articles on NiV and BBB disruption, looking for evidence of work on inflammation, immune response (cytokines and chemokines), tight junctions (TJs), and basement membranes related to NiV and BBB. Based on these works, it appears that the affinity of NiV for various receptors, including Ephrin-B2 and Ephrin-B3, has seen many NiV infections begin in the respiratory epithelium, resulting in the development of acute respiratory distress syndrome. The virus then gains entry into the circulatory system, offering it the potential to invade brain endothelial cells (ECs). NiV also has the ability to infect the leukocytes and the olfactory pathway, offering it a "Trojan horse" strategy. When NiV causes encephalitis, the CNS generates a strong inflammatory response, which makes the blood vessels more permeable. Chemokines and cytokines all have a substantial influence on BBB disruption, and NiV also has the ability to affect TJs, leading to disturbances in the structural integrity of the BBB. The pathogen's versatility is also shown by its capacity to impact multiple organ systems, despite particular emphasis on the CNS. It is of the utmost importance to comprehend the mechanisms by which NiV impacts the integrity of the BBB, as such comprehension has the potential to inform treatment approaches for NiV and other developing viral diseases. Nevertheless, the complicated pathophysiology and molecular pathways implicated in this phenomenon have offered several difficult challenges to researchers to date, underscoring the need for sustained scientific investigation and collaboration in the ongoing battle against this powerful virus.
Asunto(s)
Barrera Hematoencefálica , Infecciones por Henipavirus , Virus Nipah , Barrera Hematoencefálica/metabolismo , Barrera Hematoencefálica/virología , Virus Nipah/fisiología , Humanos , Infecciones por Henipavirus/metabolismo , Infecciones por Henipavirus/virología , Infecciones por Henipavirus/fisiopatología , Animales , Tropismo Viral/fisiologíaRESUMEN
SARS-CoV-2 has infected hundreds of millions of people with over four million dead, resulting in one of the worst global pandemics in recent history. Neurological symptoms associated with COVID-19 include anosmia, ageusia, headaches, confusion, delirium, and strokes. These may manifest due to viral entry into the central nervous system (CNS) through the blood-brain barrier (BBB) by means of ill-defined mechanisms. Here, we summarize the abilities of SARS-CoV-2 and other neurotropic RNA viruses, including Zika virus and Nipah virus, to cross the BBB into the CNS, highlighting the role of magnetic resonance imaging (MRI) in assessing presence and severity of brain structural changes in COVID-19 patients. We present new insight into key mutations in SARS-CoV-2 variants B.1.1.7 (P681H) and B.1.617.2 (P681R), which may impact on neuropilin 1 (NRP1) binding and CNS invasion. We postulate that SARS-CoV-2 may infect both peripheral cells capable of crossing the BBB and brain endothelial cells to traverse the BBB and spread into the brain. COVID-19 patients can be followed up with MRI modalities to better understand the long-term effects of COVID-19 on the brain.
Asunto(s)
Barrera Hematoencefálica , Infecciones por Henipavirus , Virus Nipah , SARS-CoV-2 , Infección por el Virus Zika , Virus Zika , Barrera Hematoencefálica/metabolismo , Barrera Hematoencefálica/fisiopatología , Barrera Hematoencefálica/virología , COVID-19/epidemiología , COVID-19/genética , COVID-19/metabolismo , COVID-19/fisiopatología , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/genética , Infecciones por Henipavirus/metabolismo , Infecciones por Henipavirus/fisiopatología , Humanos , Mutación , Virus Nipah/genética , Virus Nipah/metabolismo , SARS-CoV-2/genética , SARS-CoV-2/metabolismo , Virus Zika/genética , Virus Zika/metabolismo , Infección por el Virus Zika/epidemiología , Infección por el Virus Zika/genética , Infección por el Virus Zika/metabolismo , Infección por el Virus Zika/fisiopatologíaRESUMEN
BACKGROUND: Nipah virus (NiV) and Hendra virus (HeV) of genus Henipavirus are the deadliest zoonotic viruses, which cause severe respiratory ailments and fatal encephalitis in humans and other susceptible animals. The fatality rate for these infections had been alarmingly high with no approved treatment available to date. Viral attachment and fusion with host cell membrane is essential for viral entry and is the most essential event of viral infection. Viral attachment is mediated by interaction of Henipavirus attachment glycoprotein (G) with the host cell receptor: Ephrin B2/B3, while viral fusion and endocytosis are mediated by the combined action of both viral glycoprotein (G) and fusion protein (F). CONCLUSION: This review highlights the mechanism of viral attachment, fusion and also explains the basic mechanism and pathobiology of this infection in humans. The drugs and therapeutics used either experimentally or clinically against NiV and HeV infection have been documented and classified in detail. Some amino acid residues essential for the functionality of G and F proteins were also emphasized. Therapeutic designing to target and block these residues can serve as a promising approach in future drug development against NiV and HeV.
Asunto(s)
Antivirales/farmacología , Diseño de Fármacos , Virus Hendra/efectos de los fármacos , Virus Nipah/efectos de los fármacos , Animales , Virus Hendra/genética , Infecciones por Henipavirus/fisiopatología , Humanos , Virus Nipah/genética , Internalización del Virus/efectos de los fármacosRESUMEN
CASE SERIES: Between 2006 and 2012, there were 11 horses diagnosed with Hendra virus (HeV) on 9 independent premises in New South Wales (NSW). We defined a case of HeV as premises where one or more horses were confirmed to be infected with HeV by PCR. All the cases occurred in the north-eastern region of NSW. In 8 of the 9 cases, infection occurred within 2 months over the winter of 2011. With no exception, the affected horses were kept at pasture on properties visited by flying foxes. Of the 11 horses testing positive for HeV, 5 had an association with a fence, with the horses dead or dying on a fence line. In the majority of cases, disease was an acute illness leading to death within 48 h. When signs of disease were observed, neurological signs predominated. There was limited spread to in-contact horses, with only two properties having more than one horse affected. There was significant variation in the sampling strategies undertaken by veterinarians. CONCLUSION: Caution is needed to interpret a negative diagnosis when only swabs have been collected.
Asunto(s)
Virus Hendra/aislamiento & purificación , Infecciones por Henipavirus/veterinaria , Enfermedades de los Caballos , Animales , Resultado Fatal , Femenino , Infecciones por Henipavirus/diagnóstico , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/fisiopatología , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/epidemiología , Enfermedades de los Caballos/fisiopatología , Enfermedades de los Caballos/virología , Caballos , Masculino , Nueva Gales del Sur/epidemiología , Reacción en Cadena de la Polimerasa/veterinaria , Factores de RiesgoRESUMEN
Proteolytic activation of the fusion protein of the highly pathogenic Nipah virus (NiV F) is a prerequisite for the production of infectious particles and for virus spread via cell-to-cell fusion. Unlike other paramyxoviral fusion proteins, functional NiV F activation requires endocytosis and pH-dependent cleavage at a monobasic cleavage site by endosomal proteases. Using prototype Vero cells, cathepsin L was previously identified to be a cleavage enzyme. Compared to Vero cells, MDCK cells showed substantially higher F cleavage rates in both NiV-infected and NiV F-transfected cells. Surprisingly, this could not be explained either by an increased F endocytosis rate or by elevated cathepsin L activities. On the contrary, MDCK cells did not display any detectable cathepsin L activity. Though we could confirm cathepsin L to be responsible for F activation in Vero cells, inhibitor studies revealed that in MDCK cells, cathepsin B was required for F-protein cleavage and productive replication of pathogenic NiV. Supporting the idea of an efficient F cleavage in early and recycling endosomes of MDCK cells, endocytosed F proteins and cathepsin B colocalized markedly with the endosomal marker proteins early endosomal antigen 1 (EEA-1), Rab4, and Rab11, while NiV F trafficking through late endosomal compartments was not needed for F activation. In summary, this study shows for the first time that endosomal cathepsin B can play a functional role in the activation of highly pathogenic NiV.
Asunto(s)
Catepsina B/metabolismo , Endosomas/enzimología , Infecciones por Henipavirus/enzimología , Infecciones por Henipavirus/virología , Virus Nipah/metabolismo , Proteínas Virales de Fusión/metabolismo , Animales , Catepsina B/genética , Catepsina L/genética , Catepsina L/metabolismo , Línea Celular , Perros , Endocitosis , Endosomas/virología , Infecciones por Henipavirus/genética , Infecciones por Henipavirus/fisiopatología , Humanos , Ratones , Ratones Noqueados , Virus Nipah/genética , Proteínas Virales de Fusión/genéticaRESUMEN
Hendra virus is a highly pathogenic paramyxovirus classified as a biosafety level four agent. The fusion (F) protein of Hendra virus is critical for promoting viral entry and cell-to-cell fusion. To be fusogenically active, Hendra virus F must undergo endocytic recycling and cleavage by the endosomal/lysosomal protease cathepsin L, but the route of Hendra virus F following internalization and the recycling signals involved are poorly understood. We examined the intracellular distribution of Hendra virus F following endocytosis and showed that it is primarily present in Rab5- and Rab4-positive endosomal compartments, suggesting that cathepsin L cleavage occurs in early endosomes. Hendra virus F transmembrane domain (TMD) residues S490 and Y498 were found to be important for correct Hendra virus F recycling, with the hydroxyl group of S490 and the aromatic ring of Y498 important for this process. In addition, changes in association of isolated Hendra virus F TMDs correlated with alterations to Hendra virus F recycling, suggesting that appropriate TMD interactions play an important role in endocytic trafficking.
Asunto(s)
Endocitosis , Virus Hendra/metabolismo , Infecciones por Henipavirus/fisiopatología , Infecciones por Henipavirus/virología , Proteínas Virales de Fusión/química , Proteínas Virales de Fusión/metabolismo , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Línea Celular , Endosomas/metabolismo , Virus Hendra/química , Virus Hendra/genética , Humanos , Datos de Secuencia Molecular , Estructura Terciaria de Proteína , Transporte de Proteínas , Alineación de Secuencia , Proteínas Virales de Fusión/genéticaRESUMEN
The emergence of Hendra and Nipah viruses in the 1990s has been followed by the further emergence of these viruses in the tropical Old World. The history and current knowledge of the disease, the viruses and their epidemiology is reviewed in this article. A historical aside summarizes the role that Dr. Brian W.J. Mahy played at critical junctures in the early stories of these viruses.
Asunto(s)
Brotes de Enfermedades/prevención & control , Genoma Viral , Virus Hendra/genética , Infecciones por Henipavirus/virología , Virus Nipah/genética , Genética Inversa/métodos , Enfermedades de los Porcinos/virología , Animales , Australia/epidemiología , Bangladesh/epidemiología , Quirópteros , Control de Enfermedades Transmisibles , ADN Complementario/genética , Infecciones por Henipavirus/diagnóstico , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/fisiopatología , Humanos , Malasia/epidemiología , Plásmidos/genética , Porcinos , Enfermedades de los Porcinos/diagnóstico , Enfermedades de los Porcinos/epidemiología , Enfermedades de los Porcinos/fisiopatología , Proteínas Virales/química , Proteínas Virales/genética , Replicación ViralRESUMEN
We infected squirrel monkeys (Saimiri sciureus) with Nipah virus to determine the monkeys' suitability for use as primate models in preclinical testing of preventive and therapeutic treatments. Infection of squirrel monkeys through intravenous injection was followed by high death rates associated with acute neurologic and respiratory illness and viral RNA and antigen production.
Asunto(s)
Modelos Animales de Enfermedad , Infecciones por Henipavirus/fisiopatología , Virus Nipah/patogenicidad , Saimiri/virología , Animales , Anticuerpos Antivirales/sangre , Antígenos Virales/biosíntesis , Infecciones por Henipavirus/mortalidad , Infecciones por Henipavirus/virología , Humanos , Virus Nipah/genética , Virus Nipah/inmunología , ARN Viral/biosíntesisRESUMEN
BACKGROUND: In Bangladesh, 4 outbreaks of Nipah virus infection were identified during the period 2001-2004. METHODS: We characterized the clinical features of Nipah virus-infected individuals affected by these outbreaks. We classified patients as having confirmed cases of Nipah virus infection if they had antibodies reactive with Nipah virus antigen. Patients were considered to have probable cases of Nipah virus infection if they had symptoms consistent with Nipah virus infection during the same time and in the same community as patients with confirmed cases. RESULTS: We identified 92 patients with Nipah virus infection, 67 (73%) of whom died. Although all age groups were affected, 2 outbreaks principally affected young persons (median age, 12 years); 62% of the affected persons were male. Fever, altered mental status, headache, cough, respiratory difficulty, vomiting, and convulsions were the most common signs and symptoms; clinical and radiographic features of acute respiratory distress syndrome of Nipah illness were identified during the fourth outbreak. Among those who died, death occurred a median of 6 days (range, 2-36 days) after the onset of illness. Patients who died were more likely than survivors to have a temperature >37.8 degrees C, altered mental status, difficulty breathing, and abnormal plantar reflexes. Among patients with Nipah virus infection who had well-defined exposure to another patient infected with Nipah virus, the median incubation period was 9 days (range, 6-11 days). CONCLUSIONS: Nipah virus infection produced rapidly progressive severe illness affecting the central nervous and respiratory systems. Clinical characteristics of Nipah virus infection in Bangladesh, including a severe respiratory component, appear distinct from clinical characteristics reported during earlier outbreaks in other countries.
Asunto(s)
Infecciones por Henipavirus/patología , Infecciones por Henipavirus/fisiopatología , Adolescente , Adulto , Anticuerpos Antivirales/sangre , Bangladesh/epidemiología , Niño , Preescolar , Brotes de Enfermedades , Femenino , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Virus Nipah/inmunología , Virus Nipah/aislamiento & purificación , Radiografía Torácica , Síndrome de Dificultad Respiratoria/diagnóstico por imagen , Síndrome de Dificultad Respiratoria/patología , Síndrome de Dificultad Respiratoria/fisiopatología , Pruebas Serológicas , Factores de TiempoRESUMEN
OBJECTIVE: Nipah virus (NiV) is an emerging zoonosis. Central nervous system disease frequently results in high case-fatality. Long-term neurological assessments of survivors are limited. We assessed long-term neurologic and functional outcomes of 22 patients surviving NiV illness in Bangladesh. METHODS: During August 2005 and May 2006, we administered a questionnaire on persistent symptoms and functional difficulties to 22 previously identified NiV infection survivors. We performed neurologic evaluations and brain magnetic resonance imaging (MRI). RESULTS: Twelve (55%) subjects were male; median age was 14.5 years (range 6-50). Seventeen (77%) survived encephalitis, and 5 survived febrile illness. All but 1 subject had disabling fatigue, with a median duration of 5 months (range, 8 days-8 months). Seven encephalitis patients (32% overall), but none with febrile illness had persistent neurologic dysfunction, including static encephalopathy (n = 4), ocular motor palsies (2), cervical dystonia (2), focal weakness (2), and facial paralysis (1). Four cases had delayed-onset neurologic abnormalities months after acute illness. Behavioral abnormalities were reported by caregivers of over 50% of subjects under age 16. MRI abnormalities were present in 15, and included multifocal hyperintensities, cerebral atrophy, and confluent cortical and subcortical signal changes. INTERPRETATION: Although delayed progression to neurologic illness following Nipah fever was not observed, persistent fatigue and functional impairment was frequent. Neurologic sequelae were frequent following Nipah encephalitis. Neurologic dysfunction may persist for years after acute infection, and new neurologic dysfunction may develop after acute illness. Survivors of NiV infection may experience substantial long-term neurologic and functional morbidity.
Asunto(s)
Infecciones por Henipavirus/patología , Infecciones por Henipavirus/fisiopatología , Virus Nipah , Adolescente , Adulto , Bangladesh , Encéfalo/patología , Preescolar , Progresión de la Enfermedad , Electroencefalografía , Encefalitis/patología , Encefalitis/fisiopatología , Ensayo de Inmunoadsorción Enzimática , Fatiga/etiología , Femenino , Estudios de Seguimiento , Infecciones por Henipavirus/líquido cefalorraquídeo , Humanos , Inmunoglobulina G/análisis , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Debilidad Muscular/etiología , Enfermedades del Sistema Nervioso/etiología , Enfermedades del Sistema Nervioso/patología , Enfermedades del Sistema Nervioso/fisiopatología , Examen Neurológico , Recurrencia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Encuestas y Cuestionarios , SobrevivientesRESUMEN
Nipah (NiV) and Hendra (HeV) viruses are members of the newly defined Henipavirus genus of the Paramyxoviridae. Nipah virus (NiV) is an emergent paramyxovirus that causes fatal encephalitis in up to 70% of infected patients, and there is increasing evidence of human-to-human transmission. NiV is designated a priority pathogen in the NIAID Biodefense Research Agenda, and could be a devastating agent of agrobioterrorism if used against the pig farming industry. Endothelial syncytium is a pathognomonic feature of NiV infections, and is mediated by the fusion (F) and attachment (G) envelope glycoproteins. This review summarizes what is known about the pathophysiology of NiV infections, and documents the identification of the NiV receptor. EphrinB2, the NiV and HeV receptor, is expressed on endothelial cells and neurons, consistent with the known cellular tropism for NiV. We discuss how the identification of the henipahvirus receptor sheds light on the pathobiology of NiV infection, and how it will spur the rational development of effective therapeutics. In addition, ephrinB3, a related protein, can serve as an alternative receptor, and we suggest that differential usage of ephrinB2 versus B3 may explain the variant pathogenic profiles observed between NiV and HeV. Thus, identifying the NiV receptors opens the door for a more comprehensive analysis of the envelope-receptor interactions in NiV pathobiology. Finally, we also describe how galectin-1 (an innate immune defense lectin) can interact with specific N-glycans on the Nipah envelope fusion protein, underscoring the potential role that innate immune defense mechanisms may play against emerging pathogens.
Asunto(s)
Efrina-B2/fisiología , Efrina-B3/fisiología , Infecciones por Henipavirus/virología , Virus Nipah/patogenicidad , Receptores Virales/fisiología , Proteínas del Envoltorio Viral/fisiología , Animales , Bioterrorismo , Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/virología , Brotes de Enfermedades , Galectina 1/inmunología , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/fisiopatología , Humanos , Virus Nipah/fisiologíaRESUMEN
Hendra and Nipah virus are closely related emerging viruses comprising the Henipavirus genus of the subfamily Paramyxovirinae and are distinguished by their ability to cause fatal disease in both animal and human hosts. In particular, the high mortality and person-to-person transmission associated with the most recent Nipah virus outbreaks, as well as the very recent re-emergence of Hendra virus, has confirmed the importance and necessity of developing effective therapeutic interventions. Much research conducted on the henipaviruses over the past several years has focused on virus entry, including the attachment of virus to the host cell, the identification of the virus receptor and the membrane fusion process between the viral and host cell membranes. These findings have led to the development of possible vaccine candidates, as well as potential antiviral therapeutics. The common link among all of the possible antiviral agents discussed here, which have also been developed and tested, is that they target very early stages of the infection process. The establishment and validation of suitable animal models of Henipavirus infection and pathogenesis are also discussed as they will be crucial in the assessment of the effectiveness of any treatments for Hendra and Nipah virus infection.
Asunto(s)
Antivirales/uso terapéutico , Infecciones por Henipavirus/tratamiento farmacológico , Animales , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Antivirales/química , Gatos , Cricetinae , Modelos Animales de Enfermedad , Perros , Diseño de Fármacos , Virus Hendra/efectos de los fármacos , Virus Hendra/inmunología , Virus Hendra/patogenicidad , Infecciones por Henipavirus/fisiopatología , Infecciones por Henipavirus/prevención & control , Infecciones por Henipavirus/virología , Humanos , Ratones , Virus Nipah/efectos de los fármacos , Virus Nipah/inmunología , Virus Nipah/patogenicidad , Vacunas Virales/química , Vacunas Virales/uso terapéuticoRESUMEN
Nipah virus (NiV) is a zoonotic paramyxovirus that was first recognized in 1999 as the causative agent of outbreaks of human encephalitis in Malaysia and Singapore, in association with severe respiratory and neurological disease in pigs. Since then, outbreaks of NiV encephalitis have also occurred in Bangladesh during 2001-2004, but without an association to infected swine or other animals. Although NiV infections typically result in acute encephalitis with high mortality, other clinical manifestations, including asymptomatic infection, relapsed encephalitis, and pulmonary disease, have been observed. The article will summarize the virology, epidemiology, clinical features, treatment, and control and prevention of NiV infections in humans.
Asunto(s)
Infecciones por Henipavirus , Virus Nipah , Animales , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/fisiopatología , Humanos , Porcinos , ZoonosisRESUMEN
Numerous emerging respiratory tract viruses have been identified as significant causes of acute upper and lower respiratory tract illness in children. Human metapneumovirus is a paramyxovirus discovered in 2001 in the Netherlands, with a seasonal occurrence and spectrum of clinical illness most similar to the closely related respiratory syncytial virus. Several new members of the corona-virus family have been identified, including the truly novel agent of severe acute respiratory syndrome and others that probably have been circulating undetected. Avian influenza strains have caused numerous outbreaks with high mortality, including children, and are potential causes of pandemic influenza. Several zoonotic paramyxoviruses, including Nipah and Hendra viruses, have emerged as occasional causes of sever outbreaks of respiratory tract illness in children and adults.
Asunto(s)
Infecciones del Sistema Respiratorio/virología , Virosis , Niño , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/patología , Infecciones por Coronavirus/fisiopatología , Infecciones por Coronavirus/virología , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/patología , Infecciones por Henipavirus/fisiopatología , Infecciones por Henipavirus/virología , Humanos , Subtipo H5N1 del Virus de la Influenza A , Gripe Humana/epidemiología , Gripe Humana/patología , Gripe Humana/fisiopatología , Gripe Humana/virología , Metapneumovirus , Infecciones por Paramyxoviridae/epidemiología , Infecciones por Paramyxoviridae/patología , Infecciones por Paramyxoviridae/fisiopatología , Infecciones por Paramyxoviridae/virología , Infecciones por Virus Sincitial Respiratorio/epidemiología , Infecciones por Virus Sincitial Respiratorio/patología , Infecciones por Virus Sincitial Respiratorio/fisiopatología , Infecciones por Virus Sincitial Respiratorio/virología , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/patología , Infecciones del Sistema Respiratorio/fisiopatología , Síndrome Respiratorio Agudo Grave/epidemiología , Síndrome Respiratorio Agudo Grave/patología , Síndrome Respiratorio Agudo Grave/fisiopatología , Síndrome Respiratorio Agudo Grave/virología , Virosis/epidemiología , Virosis/patología , Virosis/fisiopatología , Virosis/virologíaRESUMEN
Nipah virus, a newly emerged zoonotic paramyxovirus, infects a number of species. Human infections were linked to direct contact with pigs, specifically with their body fluids. Clinical signs in human cases indicated primarily involvement of the central nervous system, while in pigs the respiratory system was considered the primary virus target, with only rare involvement of the central nervous system. Eleven 5-week-old piglets were infected intranasally, orally, and ocularly with 2.5 x 10(5) PFU of Nipah virus per animal and euthanized between 3 and 8 days postinoculation. Nipah virus caused neurological signs in two out of eleven inoculated pigs. The rest of the pigs remained clinically healthy. Virus was detected in the respiratory system (turbinates, nasopharynx, trachea, bronchus, and lung in titers up to 10(5.3) PFU/g) and in the lymphoreticular system (endothelial cells of blood and lymphatic vessels, submandibular and bronchiolar lymph nodes, tonsil, and spleen with titers up to 10(6) PFU/g). Virus presence was confirmed in the nervous system of both sick and apparently healthy animals (cranial nerves, trigeminal ganglion, brain, and cerebrospinal fluid, with titers up to 10(7.7) PFU/g of tissue). Nipah virus distribution was confirmed by immunohistochemistry. The study presents novel findings indicating that Nipah virus invaded the central nervous system of the porcine host via cranial nerves as well as by crossing the blood-brain barrier after initial virus replication in the upper respiratory tract.
Asunto(s)
Enfermedades Virales del Sistema Nervioso Central/veterinaria , Infecciones por Henipavirus/fisiopatología , Virus Nipah/patogenicidad , Enfermedades de los Porcinos/fisiopatología , Enfermedades de los Porcinos/virología , Animales , Barrera Hematoencefálica/virología , Encéfalo/virología , Sistema Nervioso Central/virología , Enfermedades Virales del Sistema Nervioso Central/fisiopatología , Enfermedades Virales del Sistema Nervioso Central/virología , Líquido Cefalorraquídeo/virología , Nervios Craneales/virología , Femenino , Cobayas , Infecciones por Henipavirus/virología , Humanos , Inmunohistoquímica , Porcinos , Ganglio del Trigémino/virologíaAsunto(s)
Infecciones por Henipavirus/transmisión , Virus Nipah/patogenicidad , Zoonosis , Animales , Quirópteros , Brotes de Enfermedades , Virus Hendra , Infecciones por Henipavirus/epidemiología , Infecciones por Henipavirus/fisiopatología , Infecciones por Henipavirus/terapia , Humanos , Malasia/epidemiologíaRESUMEN
The Nipah virus is a newly identified paramyxovirus responsible for an outbreak of fatal encephalitis in Malaysia and Singapore. This paper reports the follow up clinical and magnetic resonance imaging findings in 22 affected subjects. Of 13 patients with encephalitis, one died, one was lost to follow up, and seven recovered. Among the four remaining patients, one had residual sixth nerve palsy, another suffered from severe clinical depression, and a third patient had evidence of retinal artery occlusion. One patient with delayed onset Horner syndrome had a single lesion in the cervical spinal cord. The brain magnetic resonance findings were stable or improved in nine patients over 18 months of follow up. Among a second group of nine asymptomatic seropositive abattoir workers, magnetic resonance examination in seven subjects revealed discrete small lesions in the brain; similar to those detected in encephalitis patients. These findings suggest that in addition to encephalitis, the newly discovered Nipah virus affects the spinal cord and the retina. Late clinical and radiological findings can occur in Nipah virus infections as with other paramyxoviruses.